BioNTech (BNTX) News Today $106.89 -2.08 (-1.91%) Closing price 04:00 PM EasternExtended Trading$107.32 +0.42 (+0.40%) As of 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BNTX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Merz hails BioNTech founders' 'courage' as they receive German prizeJune 10 at 7:37 PM | yahoo.comRFK Jr.'s firing of CDC vaccine advisors 'circumvents science' and could threaten public health, experts sayJune 10 at 11:50 AM | cnbc.comVaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-upJune 10 at 10:07 AM | reuters.comWhy Moderna, Pfizer Stocks Are Shrugging Off RFK Jr.'s Firing of Vaccine Advisors.June 10 at 8:18 AM | barrons.comQ1 Earnings Estimate for BioNTech Issued By HC WainwrightJune 10 at 2:08 AM | americanbankingnews.comEquities Analysts Offer Predictions for BioNTech Q1 EarningsBioNTech SE (NASDAQ:BNTX - Free Report) - Investment analysts at HC Wainwright issued their Q1 2026 earnings per share estimates for shares of BioNTech in a research note issued on Thursday, June 5th. HC Wainwright analyst R. Burns anticipates that the company will post earnings of ($2.31) per shJune 9 at 1:36 AM | marketbeat.comTB Alternative Assets Ltd. Acquires Shares of 38,996 BioNTech SE (NASDAQ:BNTX)TB Alternative Assets Ltd. acquired a new stake in BioNTech SE (NASDAQ:BNTX - Free Report) during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm acquired 38,996 shares of the company's stock, valued at approximately $3,551,000. BioJune 8 at 5:41 AM | marketbeat.comBioNTech (NASDAQ:BNTX) Upgraded at Wall Street ZenWall Street Zen upgraded BioNTech from a "sell" rating to a "hold" rating in a research report on Saturday.June 7 at 3:46 AM | marketbeat.comHC Wainwright Issues Positive Forecast for BioNTech (NASDAQ:BNTX) Stock PriceJune 7 at 2:16 AM | americanbankingnews.comBristol-Myers And BioNTech Deal: Good For Both Parties, But One Is The Better InvestmentJune 6, 2025 | seekingalpha.comHC Wainwright Forecasts Strong Price Appreciation for BioNTech (NASDAQ:BNTX) StockHC Wainwright increased their price target on shares of BioNTech from $134.00 to $145.00 and gave the company a "buy" rating in a research report on Thursday.June 5, 2025 | marketbeat.comAnalysts Conflicted on These Healthcare Names: Neuren Pharmaceuticals Limited (OtherNURPF), GlaxoSmithKline (GSK) and BioNTech SE (BNTX)June 5, 2025 | theglobeandmail.comBioNTech's (BNTX) "Buy" Rating Reaffirmed at Truist FinancialJune 5, 2025 | americanbankingnews.comStrategic Partnership with BMY Boosts BioNTech’s Oncology Prospects and Financial StabilityJune 5, 2025 | tipranks.comBioNTech's Deal With Bristol Myers Over BNT-327 May Be OverhypedJune 4, 2025 | seekingalpha.comIs BioNTech Stock a Buy on Major $11 Billion Cancer-Drug Deal?June 4, 2025 | theglobeandmail.com1BNTX : 12 Analysts Have This To Say About BioNTechJune 4, 2025 | benzinga.comTruist Lifts BioNTech (BNTX) Price Target After New PartnershipJune 4, 2025 | msn.comBioNTech SE (NASDAQ:BNTX) Shares Sold by Mackenzie Financial CorpMackenzie Financial Corp lowered its stake in shares of BioNTech SE (NASDAQ:BNTX - Free Report) by 83.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,903 shares of the company'sJune 4, 2025 | marketbeat.comBristol Myers CEO explains why he’s spending billions on BioNTech dealJune 3, 2025 | msn.comBioNTech (NasdaqGS:BNTX) Enters Global Co-Development Agreement With Bristol Myers SquibbJune 3, 2025 | finance.yahoo.comBioNTech (NASDAQ:BNTX) Sees Large Volume Increase - Here's WhyBioNTech (NASDAQ:BNTX) Sees Unusually-High Trading Volume - Here's What HappenedJune 3, 2025 | marketbeat.comBioNTech (NASDAQ:BNTX) Shares Gap Up - Time to Buy?BioNTech (NASDAQ:BNTX) Shares Gap Up - Here's What HappenedJune 3, 2025 | marketbeat.comBioNTech (NASDAQ:BNTX) Given Buy Rating at Truist FinancialTruist Financial reissued a "buy" rating and set a $155.00 target price (up previously from $151.00) on shares of BioNTech in a research report on Tuesday.June 3, 2025 | marketbeat.comWhy BioNTech SE (BNTX) Skyrocketed On MondayJune 3, 2025 | msn.comStock Movers: BioNTech, Boeing, NucorJune 2, 2025 | bloomberg.comWhy BioNTech Stock Soared TodayJune 2, 2025 | msn.comBioNTech and Bristol Myers Squibb Launch $11.1 Billion Partnership to Advance Cancer ImmunotherapyJune 2, 2025 | msn.comBioNTech Sets Cancer-Drug Deal With Bristol Myers SquibbJune 2, 2025 | wsj.comBioNTech SE and Bristol Myers Squibb Collaborate on Promising Cancer Immunotherapy | BNTX stock newsJune 2, 2025 | gurufocus.comBristol Myers to pay $1.5 billion upfront for BioNTech cancer drug partnershipJune 2, 2025 | reuters.comBioNTech and Bristol Myers Squibb Announce Global Strategic Partnership to Co-Develop and Co-Commercialize Next-generation Bispecific Antibody Candidate BNT327 Broadly for Multiple Solid Tumor TypesJune 2, 2025 | globenewswire.comBioNTech SE: Hold Rating Amid Mixed Clinical Trial Results for BNT327June 1, 2025 | tipranks.comGTS Securities LLC Sells 28,048 Shares of BioNTech SE (NASDAQ:BNTX)GTS Securities LLC lowered its position in shares of BioNTech SE (NASDAQ:BNTX - Free Report) by 93.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,937 shares of the company's stock after selling 28,04June 1, 2025 | marketbeat.comBioNTech (NASDAQ:BNTX) Stock Rating Lowered by Wall Street ZenJune 1, 2025 | americanbankingnews.comWall Street Zen Downgrades BioNTech (NASDAQ:BNTX) to SellWall Street Zen lowered BioNTech from a "hold" rating to a "sell" rating in a research report on Friday.June 1, 2025 | marketbeat.comBioNTech (NASDAQ:BNTX) Shares Gap Down - Time to Sell?BioNTech (NASDAQ:BNTX) Shares Gap Down - Should You Sell?May 31, 2025 | marketbeat.comBioNTech (NASDAQ:BNTX) Upgraded by The Goldman Sachs Group to "Hold" RatingThe Goldman Sachs Group raised BioNTech to a "hold" rating in a report on Thursday.May 31, 2025 | marketbeat.comJefferies Financial Group Inc. Purchases New Position in BioNTech SE (NASDAQ:BNTX)Jefferies Financial Group Inc. bought a new position in shares of BioNTech SE (NASDAQ:BNTX - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 5,000 shares of the company's stock, valued at aMay 31, 2025 | marketbeat.comGoldman Sachs Initiates Coverage of BioNTech SE - Depositary Receipt () (BNTX) with Neutral RecommendationMay 30, 2025 | msn.comBioNTech SE: Hold Rating Amid Market Challenges and Promising Oncology ProspectsMay 29, 2025 | tipranks.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Grows Stock Holdings in BioNTech SE (NASDAQ:BNTX)UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in BioNTech SE (NASDAQ:BNTX - Free Report) by 19.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 221,080 shares of the company'sMay 29, 2025 | marketbeat.comBioNTech SE: BioNTech to Present Progress Across Diversified Oncology Pipeline at the 2025 ASCO Annual MeetingMay 27, 2025 | finanznachrichten.deBioNTech to Present Progress Across Diversified Oncology Pipeline at the 2025 ASCO Annual MeetingMay 27, 2025 | globenewswire.comUSS Investment Management Ltd Invests $3.12 Million in BioNTech SE (NASDAQ:BNTX)USS Investment Management Ltd purchased a new position in BioNTech SE (NASDAQ:BNTX - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 27,850 shares of the company's stock, valued at approximaMay 26, 2025 | marketbeat.comBioNTech SE (NASDAQ:BNTX) Stake Cut by Bank of America Corp DEBank of America Corp DE cut its position in shares of BioNTech SE (NASDAQ:BNTX - Free Report) by 65.2% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 74,451 shares of the company's stock after selling 139,203 sharesMay 26, 2025 | marketbeat.comBioNTech’s SWOT analysis: oncology pipeline and mRNA tech drive stock potentialMay 24, 2025 | investing.comJPMorgan Chase & Co. Issues Pessimistic Forecast for BioNTech (NASDAQ:BNTX) Stock PriceJPMorgan Chase & Co. reduced their target price on BioNTech from $120.00 to $116.00 and set a "neutral" rating for the company in a report on Thursday.May 24, 2025 | marketbeat.comBioNTech's (BNTX) "Buy" Rating Reaffirmed at HC WainwrightHC Wainwright restated a "buy" rating and issued a $134.00 price objective on shares of BioNTech in a report on Thursday.May 24, 2025 | marketbeat.comBioNTech SE (NASDAQ:BNTX) Shares Sold by Voloridge Investment Management LLCVoloridge Investment Management LLC lowered its stake in shares of BioNTech SE (NASDAQ:BNTX - Free Report) by 12.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 351,095 shares of the company's stock aMay 23, 2025 | marketbeat.com Get BioNTech News Delivered to You Automatically Sign up to receive the latest news and ratings for BNTX and its competitors with MarketBeat's FREE daily newsletter. Email Address BNTX Media Mentions By Week BNTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BNTX News Sentiment▼0.370.68▲Average Medical News Sentiment BNTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BNTX Articles This Week▼2312▲BNTX Articles Average Week Get BioNTech News Delivered to You Automatically Sign up to receive the latest news and ratings for BNTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies GSK News Today Takeda Pharmaceutical News Today argenx News Today Beigene News Today Teva Pharmaceutical Industries News Today Summit Therapeutics News Today Genmab A/S News Today Intra-Cellular Therapies News Today Dr. Reddy's Laboratories News Today Moderna News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BNTX) was last updated on 6/10/2025 by MarketBeat.com Staff From Our PartnersElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredGet Ready for Elon Musk’s BIGGEST Comeback YetTesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored50-year legend: Here’s exact day stocks will crashGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioNTech SE Please log in to your account or sign up in order to add this asset to your watchlist. Share BioNTech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BNTX Stock Free BNTX Stock Alerts